CCM
HALO icon

Covington Capital Management’s Halozyme HALO Stock Holding History

Covington Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$9.79M Hold
247,500
– – 0.42% 74
2022
Q2 		$10.9M Buy
+247,500
New +$10.7M 0.44% 69

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covington Capital Management's HALO Position: Q3 2022 in Review

Covington Capital Management held its Halozyme (HALO) position steady in Q3 2022 at 247,500 shares worth $9.79M. The position accounts for 0.42% of the portfolio, ranked #74.

Covington Capital Management first reported a position in HALO in Q2 2022 and has held it in 2 quarters since. The position peaked at $10.9M in Q2 2022. 358 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

  • Covington Capital Management held 247,500 shares of Halozyme worth $9.79M as of Q3 2022.
  • Covington Capital Management left its Halozyme share count unchanged in Q3 2022.
  • Halozyme made up 0.42% of Covington Capital Management's portfolio in Q3 2022, its #74 holding.
  • Covington Capital Management first reported a position in Halozyme in Q2 2022 and has held it in 2 quarters since.
  • Covington Capital Management's Halozyme position peaked at $10.9M in Q2 2022.
  • 358 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.